BioSpecifics Technologies Corporation

218 articles with BioSpecifics Technologies Corporation

• BioSpecifics Technologies Corporation to Present at CapStone Investments' Third Annual Small-Cap Investor Conference

  7/23/2009

• BioSpecifics Technologies Corporation Added to Russell 3000 and Russell 2000 Indexes

  6/30/2009

• BioSpecifics Technologies Corporation Reports First Quarter 2009 Financial Results

  5/11/2009

• BioSpecifics Technologies Corporation Announces FDA Acceptance of Biologics License Application With Priority Review for XIAFLEX(TM) for the Treatment of Dupuytren's Disease

  4/29/2009

• BioSpecifics Technologies Corporation Reports Fourth Quarter and Full Year 2008 Financial Results

  3/31/2009

• BioSpecifics Technologies Corporation Announces Listing on NASDAQ Global Market

  1/7/2009

• Pfizer Inc. (JOBS) Buys Rights to Market Auxilium Pharmaceuticals's Key Drug; $410 Million in Potential Milestone Payments

  12/18/2008

• BioSpecifics Technologies Corporation to Present at Rodman & Renshaw 10th Annual Healthcare Conference

  11/7/2008

• BioSpecifics Technologies Corporation Announces Appointment of Dr. Matthew Geller to Board of Directors

  9/25/2008

• BioSpecifics Technologies Corporation Announces Initiation of Phase IIb Trial for Peyronie's Disease

  9/17/2008

• BioSpecifics Technologies Corporation Buys Down Royalties for Peyronie's Disease

  9/5/2008

• BioSpecifics Technologies Corporation Announces Private Placement Offering

  8/25/2008

• BioSpecifics Technologies Corporation Announces Additional Sales of Stock in Private Placement Offering

  6/11/2008

• BioSpecifics Technologies Corporation Announces Sale of Stock in Private Placement Offering

  6/4/2008

• BioSpecifics Technologies Corporation Announces Repayment of Outstanding Loan

  2/6/2008

• BioSpecifics Technologies Corporation Announces Sale of Stock in Private Placement Offering

  1/15/2008

• BioSpecifics Technologies Corporation Mourns Death Of Chairman And CEO Edwin H. Wegman

  2/21/2007

• Healthpoint Acquires Collagenase Topical Business From BioSpecifics Technologies Corporation

  3/7/2006